Human hemato-lymphoid system mice: Current use and future potential for medicine

Annual Review of Immunology

Volumn 31, Issue , 2013, Pages 635-674

  Rongvaux, Anthony ^a   Takizawa, Hitoshi ^c   Strowig, Till ^a   Willinger, Tim ^a   Eynon, Elizabeth E ^a   Flavell, Richard A ^a,b   Manz, Markus G ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cancer; Hematopoiesis; Humanized mice; Infectious disease; Stem cells

Indexed keywords

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CROSS REACTION; DENDRITIC CELL; DENGUE VIRUS; DONOR; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ERYTHROPOIESIS; GENE THERAPY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC SYSTEM; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LYMPH NODE; LYMPHATIC SYSTEM; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHI; SOLID TUMOR; T LYMPHOCYTE; THROMBOCYTOPOIESIS;

ANIMALS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; LYMPHOID TISSUE; MICE; MODELS, ANIMAL; TRANSLATIONAL MEDICAL RESEARCH; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875548150     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032712-095921     Document Type: Review

References (207)

1. McCune J, Kaneshima H, Krowka J, Namikawa R, Outzen H, et al. 1991. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu. Rev. Immunol. 9:399-429
2. Murphy WJ, Pringle TH, Crider TA, Springer MS, MillerW. 2007. Using genomic data to unravel the root of the placental mammal phylogeny. Genome Res. 17:413-21
3. BarreiroLB, Quintana-Murci L. 2010. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat. Rev. Genet. 11:17-30
4. Sabeti PC, Schaffner SF, Fry B, Lohmueller J, Varilly P, et al. 2006. Positive natural selection in the human lineage. Science 312:1614-20
5. Lee YK, Mazmanian SK. 2010. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330:1768-73
6. OhnmachtC, Marques R, Presley L, Sawa S, LochnerM, Eberl G. 2011. Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity. Cell. Microbiol. 13:653-59
7. Hooper LV, Littman DR, Macpherson AJ. 2012. Interactions between the microbiota and the immune system. Science 336:1268-73
8. Sansonetti PJ, Medzhitov R. 2009. Learning tolerance while fighting ignorance. Cell 138:416-20
9. Walter J, Ley R. 2011. The human gut microbiome: ecology and recent evolutionary changes. Annu. Rev. Microbiol. 65:411-29
10. Spor A, Koren O, Ley R. 2011. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat. Rev. Microbiol. 9:279-90
11. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, et al. 2012. Host-gut microbiota metabolic interactions. Science 336:1262-67
12. Pearce-Duvet JM. 2006. The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease. Biol. Rev. Camb. Philos. Soc. 81:369-82
13. Diamond J. 2002. Evolution, consequences and future of plant and animal domestication. Nature 418:700-7
14. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. 2011. Human nutrition, the gut microbiome and the immune system. Nature 474:327-36
15. Dorshkind K, Montecino-Rodriguez E, Signer RA. 2009. The ageing immune system: Is it ever too old to become young again? Nat. Rev. Immunol. 9:57-62
16. Shanley DP, Aw D, Manley NR, Palmer DB. 2009. An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol. 30:374-81
17. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. 2011. Natural innate and adaptive immunity to cancer. Annu. Rev. Immunol. 29:235-71
18. Haley PJ. 2003. Species differences in the structure and function of the immune system. Toxicology 188:49-71
19. Mestas J, Hughes CC. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172:2731-38
20. Quintana-Murci L, Alcais A, Abel L, Casanova JL. 2007. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 8:1165-71
21. Bosma GC, Custer RP, Bosma MJ. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-30
22. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335:256-59
23. McCune JM, Namikawa R, Kaneshima H, Shultz LD, LiebermanM, Weissman IL. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-39
24. Schatz DG, Oettinger MA, Baltimore D. 1989. The V(D)J recombination activating gene, RAG-1. Cell 59:1035-48
25. Mombaerts P, Iacomini J, Johnson RS, HerrupK, Tonegawa S, PapaioannouVE. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-77
26. Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, et al. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68:855-67
27. Shultz LD, Lang PA, Christianson SW, Gott B, Lyons B, et al. 2000. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistantmodel for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164:2496-507
28. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, et al. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104-7
29. Di Santo JP. 2006. Natural killer cell developmental pathways: a question of balance. Annu. Rev. Immunol. 24:257-86
30. + cells. Blood 99:1620-26
31. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. 2002. NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175-82
32. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, et al. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γchainnull mice. Blood 106:1565-73
33. Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, et al. 2007. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat. Immunol. 8:1313-23
34. Takizawa H, Manz MG. 2007. Macrophage tolerance: CD47-SIRP-α- mediated signals matter. Nat. Immunol. 8:1287-89
35. Strowig T, Rongvaux A, Rathinam C, Takizawa H, Borsotti C, et al. 2011. Transgenic expression of human signal regulatory protein αin Rag2-/-γc-/-mice improves engraftment of human hematopoietic cells in humanized mice. Proc. Natl. Acad. Sci. USA 108:13218-23
36. Legrand N, Huntington ND, Nagasawa M, Bakker AQ, Schotte R, et al. 2011. Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T-and natural killer-(NK) cell homeostasis in vivo. Proc. Natl. Acad. Sci. USA 108:13224-29
37. van Rijn RS, Simonetti ER, Hagenbeek A, Hogenes MC, de Weger RA, et al. 2003. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/-γc-/- double-mutant mice. Blood 102:2522-31
38. Verlinden SF, Mulder AH, de Leeuw JP, van Bekkum DW. 1998. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation. Stem Cells 16(Suppl. 1):205-17
39. Hayakawa J, Hsieh MM, Uchida N, Phang O, Tisdale JF. 2009. Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2RγNull mice. Stem Cells 27:175-82
40. Czechowicz A, Kraft D, Weissman IL, Bhattacharya D. 2007. Efficient transplantation via antibodybased clearance of hematopoietic stem cell niches. Science 318:1296-99
41. Lapidot T, Dar A, Kollet O. 2005. How do stem cells find their way home? Blood 106:1901-10
42. Lapidot T, Kollet O. 2002. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2mnull mice. Leukemia 16:1992-2003
43. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. 2001. Physiological migration of hematopoietic stem and progenitor cells. Science 294:1933-36
44. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, et al. 1999. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-48
45. Manz MG. 2007. Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 26:537-41
46. + cells injected into newborn RAG2-/-γc-/-mice: functional inactivation of p53 in developing T cells. Blood 104:3886-93
47. Legrand N, Weijer K, Spits H. 2006. Experimental models to study development and function of the human immune system in vivo. J. Immunol. 176:2053-58
48. Mazurier F, DoedensM, Gan OI, Dick JE. 2003. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat. Med. 9:959-63
49. KondoM, Wagers AJ, Manz MG, Prohaska SS, Scherer DC, et al. 2003. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 21:759-806
50. Doulatov S, Notta F, Laurenti E, Dick JE. 2012. Hematopoiesis: a human perspective. Cell Stem Cell 10:120-36
51. Choi EY, Jung KC, Park HJ, Chung DH, Song JS, et al. 2005. Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells. Immunity 23:387-96
52. Li W, KimMG, Gourley TS, McCarthy BP, Sant'Angelo DB, Chang CH. 2005. An alternate pathway for CD4 T cell development: thymocyte-expressed MHC class II selects a distinct T cell population. Immunity 23:375-86
53. Shultz LD, Ishikawa F, Greiner DL. 2007. Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7:118-30
54. Kamel-Reid S, Dick JE. 1988. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242:1706-9
55. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. 1992. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137-41
56. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154:180-91
57. Hesselton RM, Greiner DL, Mordes JP, Rajan TV, Sullivan JL, Shultz LD. 1995. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J. Infect. Dis. 172:974-82
58. + T cell engraftment in beta2-microglobulin- deficient NOD-scid mice. J. Immunol. 158:3578-86
59. Shultz LD, Banuelos S, Lyons B, Samuels R, Burzenski L, et al. 2003. NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation 76:1036-42
60. Mazurier F, Fontanellas A, Salesse S, Taine L, Landriau S, et al. 1999. A novel immunodeficient mouse model-RAG2 x common cytokine receptor γ chain double mutants-requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J. Interferon Cytokine Res. 19:533-41
61. + cell transplantation. Blood 108:487-92
62. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, et al. 2006. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat. Med. 12:1316-22
63. Denton PW, Garcia JV. 2011. Humanized mouse models of HIV infection. AIDS Rev. 13:135-48
64. Doulatov S, Notta F, Eppert K, Nguyen LT, Ohashi PS, Dick JE. 2010. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat. Immunol. 11:585-93
65. Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE. 2011. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333:218-21
66. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. 1992. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 89:2804-8
67. Majeti R, Park CY, Weissman IL. 2007. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1:635-45
68. PangWW, Price EA, Sahoo D, Beerman I, MaloneyWJ, et al. 2011. Human bonemarrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc. Natl. Acad. Sci. USA 108:20012-17
69. Takizawa H, Schanz U, Manz MG. 2011. Ex vivo expansion of hematopoietic stem cells: mission accomplished? Swiss Med. Wkly. 141:w13316
70. Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, et al. 2010. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329:1345-48
71. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-48
72. Bonnet D, Dick JE. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3:730-37
73. Dick JE. 2008. Stem cell concepts renew cancer research. Blood 112:4793-807
74. Reya T, Morrison SJ, Clarke MF, Weissman IL. 2001. Stem cells, cancer, and cancer stem cells. Nature 414:105-11
75. Magee JA, Piskounova E, Morrison SJ. 2012. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21:283-96
76. Meyer LH, Eckhoff SM, Queudeville M, Kraus JM, Giordan M, et al. 2011. Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways. Cancer Cell 19:206-17
77. Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, et al. 2010. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464:852-57
78. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. 2006. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12:1167-74
79. Jin L, Lee EM, Ramshaw HS, Busfield SJ, Peoppl AG, et al. 2009. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor α chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell 5:31-42
80. Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, et al. 2010. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell 7:708-17
81. Majeti R, Chao MP, Alizadeh AA, PangWW, Jaiswal S, et al. 2009. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 138:286-99
82. Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, et al. 2010. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat. Biotechnol. 28:275-80
83. Ramer PC, Chijioke O, Meixlsperger S, Leung CS, Munz C. 2011. Mice with human immune system components as in vivo models for infections with human pathogens. Immunol. Cell Biol. 89:408-16
84. Namikawa R, KaneshimaH, Lieberman M, Weissman IL, McCune JM. 1988. Infection of the SCID-hu mouse by HIV-1. Science 242:1684-86
85. Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA. 1991. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251:791-94
86. + cord blood cell-transplanted Rag2-/-γc-/-mice. Proc. Natl. Acad. Sci. USA 103:15951-56
87. Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R. 2006. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/-(RAG-hu) mouse model. Retrovirology 3:76
88. Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, et al. 2007. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-γc-/-mice. J. Virol. 81:2700-12
89. Zhang L, Kovalev GI, Su L. 2007. HIV-1 infection and pathogenesis in a novel humanizedmousemodel. Blood 109:2978-81
90. Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, et al. 2007. Humanized NOD/SCID/IL2Rγnull mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J. Virol. 81:13259-64
91. BrainardDM, Seung E, Frahm N, Cariappa A, Bailey CC, et al. 2009. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J. Virol. 83:7305-21
92. Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, et al. 2008. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 5:e16
93. + T cell depletion in humanized mice infected with HIV-1. J. Exp.Med. 204:705-14
94. Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, et al. 2009. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J. Exp. Med. 206:1423-34
95. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, et al. 2009. T cell-mediated control of Epstein-Barr virus infection in humanized mice. J. Infect. Dis. 200:1611-15
96. Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, et al. 2011. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J. Virol. 85:165-77
97. White RE, Ramer PC, Naresh KN, Meixlsperger S, Pinaud L, et al. 2012. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J. Clin. Investig. 122:1487-502
98. Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, et al. 2008. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 112:1231-39
99. Murphy BR, Whitehead SS. 2011. Immune response to Dengue virus and prospects for a vaccine. Annu. Rev. Immunol. 29:587-619
100. Mota J, Rico-Hesse R. 2009. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J. Virol. 83:8638-45
101. Kuruvilla JG, Troyer RM, Devi S, Akkina R. 2007. Dengue virus infection and immune response in humanized RAG2-/-γc-/-(RAG-hu) mice. Virology 369:143-52
102. Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, et al. 2009. Dengue virus infection and virusspecific HLA-A2 restricted immune responses in humanized NOD-scid IL2rγnull mice. PLoS ONE 4:e7251
103. Song J, Willinger T, Rongvaux A, Eynon EE, Stevens S, et al. 2010. A mouse model for the human pathogen Salmonella Typhi. Cell Host Microbe 8:369-76
104. Libby SJ, Brehm MA, Greiner DL, Shultz LD, McClelland M, et al. 2010. Humanized nonobese diabetic-scid IL2rγnull mice are susceptible to lethal Salmonella Typhi infection. Proc. Natl. Acad. Sci. USA 107:15589-94
105. Kwant-Mitchell A, Ashkar AA, Rosenthal KL. 2009. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J. Virol. 83:10664-76
106. Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, et al. 2011. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 140:1334-44
107. Robinet E, Baumert TF. 2011. A first step towards a mouse model for hepatitis C virus infection containing a human immune system. J. Hepatol. 55:718-20
108. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10:943-48
109. Sandor M, Weinstock JV, Wynn TA. 2003. Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol. 24:44-52
110. Sharma P, Wagner K, Wolchok JD, Allison JP. 2011. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat. Rev. Cancer 11:805-12
111. + T cells that facilitate tumor development. J. Exp. Med. 204:1037-47
112. Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, et al. 2011. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J. Exp. Med. 208:479-90
113. Brehm MA, Bortell R, Diiorio P, Leif J, Laning J, et al. 2010. Human immune system development and rejection of human islet allografts in spontaneously diabetic NOD-Rag1null IL2rγnull Ins2Akita mice. Diabetes 59:2265-70
114. O'Boyle G, Fox CR, Walden HR, Willet JD, Mavin ER, et al. 2012. Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation. Proc. Natl. Acad. Sci. USA 109:4598-603
115. Kalscheuer H, Danzl N, Onoe T, Faust T, Winchester R, et al. 2012. A model for personalized in vivo analysis of human immune responsiveness. Sci. Transl. Med. 4:125ra30
116. Kumar P, Ban HS, Kim SS, Wu H, Pearson T, et al. 2008. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134:577-86
117. + T cells by genome editing using zinc-finger nucleases. Nat. Biotechnol. 26:808-16
118. Neagu MR, Ziegler P, Pertel T, Strambio-De-Castillia C, Grutter C, et al. 2009. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J. Clin. Investig. 119:3035-47
119. Holt N, Wang J, Kim K, FriedmanG, Wang X, et al. 2010. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat. Biotechnol. 28:839-47
120. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, et al. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415-19
121. Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, et al. 2010. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat. Med. 16:198-204
122. Biffi A, Bartolomae CC, Cesana D, Cartier N, Aubourg P, et al. 2011. Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 117:5332-39
123. Manz MG, Di Santo JP. 2009. Renaissance for mouse models of human hematopoiesis and immunobiology. Nat. Immunol. 10:1039-42
124. WillingerT, RongvauxA, Strowig T, ManzMG, FlavellRA. 2011. Improving human hemato-lymphoidsystem mice by cytokine knock-in gene replacement. Trends Immunol. 32:321-27
125. Nicolini FE, Cashman JD, Hogge DE, Humphries RK, Eaves CJ. 2004. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia 18:341-47
126. Rongvaux A, Willinger T, Takizawa H, Rathinam C, Auerbach W, et al. 2011. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc. Natl. Acad. Sci. USA 108:2378-83
127. Willinger T, Rongvaux A, Takizawa H, Yancopoulos GD, Valenzuela DM, et al. 2011. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc. Natl. Acad. Sci. USA 108:2390-95
128. Rathinam C, Poueymirou WT, Rojas J, Murphy AJ, Valenzuela DM, et al. 2011. Efficient differentiation and function of human macrophages in humanized CSF-1 mice. Blood 118:3119-28
129. Fox N, Priestley G, Papayannopoulou T, Kaushansky K. 2002. Thrombopoietin expands hematopoietic stem cells after transplantation. J. Clin. Investig. 110:389-94
130. Kirito K, Fox N, Kaushansky K. 2003. Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells. Blood 102:3172-78
131. Qian H, Buza-Vidas N, HylandCD, Jensen CT, Antonchuk J, et al. 2007. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 1:671-84
132. YoshiharaH, Arai F, Hosokawa K, Hagiwara T, Takubo K, et al. 2007. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1:685-97
133. McCarthy KF, Ledney GD, Mitchell R. 1977. A deficiency of hematopoietic stem cells in steel mice. Cell Tissue Kinet. 10:121-26
134. Brehm MA, Racki WJ, Leif J, Burzenski L, Hosur V, et al. 2012. Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγnull mice is enhanced by transgenic expression of membranebound human SCF. Blood 119:2778-88
135. Takagi S, Saito Y, Hijikata A, Tanaka S, Watanabe T, et al. 2012. Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiation. Blood 119:2768-77
136. Wilson A, Trumpp A. 2006. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 6:93-106
137. Kiel MJ, Morrison SJ. 2008. Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol. 8:290-301
138. Mercier FE, Ragu C, Scadden DT. 2012. The bone marrow at the crossroads of blood and immunity. Nat. Rev. Immunol. 12:49-60
139. Hattangadi SM, Wong P, Zhang L, Flygare J, Lodish HF. 2011. From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications. Blood 118:6258-68
140. Chen Q, KhouryM, Chen J. 2009. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc. Natl. Acad. Sci. USA 106:21783-88
141. Hu Z, Van Rooijen N, Yang YG. 2011. Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood 118:5938-46
142. Kaushansky K. 2008. Historical review: megakaryopoiesis and thrombopoiesis. Blood 111:981-86
143. Hu Z, Yang YG. 2012. Full reconstitution of human platelets in humanized mice after macrophage depletion. Blood 120:1713-16
144. Tanaka S, Saito Y, Kunisawa J, Kurashima Y, Wake T, et al. 2012. Development ofmature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rγKO mice. J. Immunol. 188:6145-55
145. Gille C, Orlikowsky TW, Spring B, Hartwig UF, Wilhelm A, et al. 2012. Monocytes derived from humanized neonatal NOD/SCID/IL2Rγnull mice are phenotypically immature and exhibit functional impairments. Hum. Immunol. 73:346-54
146. Bock TA, Orlic D, Dunbar CE, Broxmeyer HE, Bodine DM. 1995. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J. Exp. Med. 182:2037-43
147. Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, et al. 2010. AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 24:1785-88
148. + regulatory T cells in human stem cell factor-, granulocyte-macrophage colonystimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγnull humanized mice. Blood 117:3076-86
149. Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, et al. 1994. Involvement of granulocytemacrophage colony-stimulating factor in pulmonary homeostasis. Science 264:713-16
150. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, et al. 1994. Granulocyte/macrophage colonystimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91:5592-96
151. Auffray C, Sieweke MH, Geissmann F. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27:669-92
152. Serbina NV, Jia T, Hohl TM, Pamer EG. 2008. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26:421-52
153. Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11:762-74
154. Chow A, Brown BD, Merad M. 2011. Studying the mononuclear phagocyte system in the molecular age. Nat. Rev. Immunol. 11:788-98
155. Steinman RM. 2012. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30:1-22
156. HeathWR, Carbone FR. 2009. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10:1237-44
157. Merad M, Manz MG. 2009. Dendritic cell homeostasis. Blood 113:3418-27
158. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327:656-61
159. + dendritic cells. J. Exp. Med. 207:1131-34
160. + dendritic cells. J. Exp. Med. 207:1261-71
161. Ishikawa F, Niiro H, Iino T, Yoshida S, Saito N, et al. 2007. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood 110:3591-660
162. Jung KC, Park CG, Jeon YK, Park HJ, Ban YL, et al. 2011. In situ induction of dendritic cell-based T cell tolerance in humanized mice and nonhuman primates. J. Exp. Med. 208:2477-88
163. Lanier LL. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-74
164. Di Santo JP. 2008. Natural killer cells: diversity in search of a niche. Nat. Immunol. 9:473-75
165. Huntington ND, Vosshenrich CA, Di Santo JP. 2007. Developmental pathways that generate naturalkiller-cell diversity in mice and humans. Nat. Rev. Immunol. 7:703-14
166. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. 2012. Targeting natural killer cells and natural killer T cells in cancer. Nat. Rev. Immunol. 12:239-52
167. Barten R, Torkar M, Haude A, Trowsdale J, Wilson MJ. 2001. Divergent and convergent evolution of NK-cell receptors. Trends Immunol. 22:52-57
168. Ma A, Koka R, Burkett P. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24:657-79
169. + T cell maintenance and a functional arrest of immature NK cells. J. Immunol. 185:2710-20
170. StrowigT, ChijiokeO, Carrega P, Arrey F, Meixlsperger S, et al. 2010. HumanNK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116:4158-67
171. Kwant-Mitchell A, Pek EA, Rosenthal KL, Ashkar AA. 2009. Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge. PLoS ONE 4:e8379
172. Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, et al. 2009. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206:25-34
173. Pek EA, Chan T, Reid S, Ashkar AA. 2011. Characterization and IL-15 dependence of NK cells in humanized mice. Immunobiology 216:218-24
174. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, et al. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174:6477-89
175. Danner R, Chaudhari SN, Rosenberger J, Surls J, Richie TL, et al. 2011. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS ONE 6:e19826
176. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, et al. 2010. Generation of functional human Tcell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice. Proc. Natl. Acad. Sci. USA 107:13022-27
177. Suzuki M, Takahashi T, Katano I, Ito R, Ito M, et al. 2012. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse. Int. Immunol. 24:243-52
178. Takada K, Jameson SC. 2009. Naive T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 9:823-32
179. van Lent AU, Dontje W, Nagasawa M, Siamari R, Bakker AQ, et al. 2009. IL-7 enhances thymic human T cell development in human immune system Rag2-/-IL-2Rγc-/-mice without affecting peripheral T cell homeostasis. J. Immunol. 183:7645-55
180. O'Connell RM, Balazs AB, Rao DS, Kivork C, Yang L, Baltimore D. 2010.
181. Huntington ND, Alves NL, Legrand N, Lim A, Strick-MarchandH, et al. 2011. IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proc. Natl. Acad. Sci. USA 108:6217-22
182. Hardy RR, Hayakawa K. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595-621
183. + cells. Exp.Hematol. 31:789-97
184. Ippolito GC, Hoi KH, Reddy ST, Carroll SM, Ge X, et al. 2012. Antibody repertoires in humanized NOD-scid-IL2Rγnull mice and human B cells reveals human-like diversification and tolerance checkpoints in the mouse. PLoS ONE 7:e35497
185. Pham HP, Manuel M, Petit N, Klatzmann D, Cohen-Kaminsky S, et al. 2012. Half of the T-cell repertoire combinatorial diversity is genetically determined in humans and humanized mice. Eur. J. Immunol. 42:760-70
186. Chang H, Biswas S, Tallarico AS, Sarkis PT, Geng S, et al. 2012. Human B-cell ontogeny in humanized NOD/SCID γcnull mice generates a diverse yet auto/poly-and HIV-1-reactive antibody repertoire. Genes Immun. 13:399-410
187. Marodon G, Desjardins D, Mercey L, Baillou C, Parent P, et al. 2009. High diversity of the immune repertoire in humanized NOD.SCID.γc-/-mice. Eur. J. Immunol. 39:2136-45
188. Small TN, Keever CA, Weiner-Fedus S, HellerG, O'Reilly RJ, FlomenbergN. 1990. B-cell differentiation following autologous, conventional, or T-cell depleted bonemarrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 76:1647-56
189. Schmidt MR, Appel MC, Giassi LJ, Greiner DL, Shultz LD, Woodland RT. 2008. Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice. PLoS ONE 3:e3192
190. Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, et al. 2012. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 150:194-206
191. Fu YX, Huang G, Wang Y, Chaplin DD. 1998. B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion. J. Exp. Med. 187:1009-18
192. Roozendaal R, Mebius RE. 2011. Stromal cell-immune cell interactions. Annu. Rev. Immunol. 29:23-43
193. MacLennan IC. 1994. Germinal centers. Annu. Rev. Immunol. 12:117-39
194. Gonzalez M, Mackay F, Browning JL, Kosco-Vilbois MH, Noelle RJ. 1998. The sequential role of lymphotoxin and B cells in the development of splenic follicles. J. Exp. Med. 187:997-1007
195. Randall TD, Carragher DM, Rangel-Moreno J. 2008. Development of secondary lymphoid organs. Annu. Rev. Immunol. 26:627-50
196. Coles MC, Veiga-Fernandes H, Foster KE, Norton T, Pagakis SN, et al. 2006. Role of T and NK cells and IL7/IL7r interactions during neonatal maturation of lymph nodes. Proc. Natl. Acad. Sci. USA 103:13457-62
197. Denton PW, NochiT, Lim A, Krisko JF, Martinez-Torres F, et al. 2012. IL-2 receptorγ-chain molecule is critical for intestinal T-cell reconstitution in humanized mice. Mucosal Immunol. 5:555-66
198. + hematopoietic progenitors. Blood 102:3302-10
199. Dash PK, Gorantla S, Gendelman HE, Knibbe J, Casale GP, et al. 2011. Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J. Neurosci. 31:3148-57
200. Berges BK, Akkina SR, Folkvord JM, Connick E, Akkina R. 2008. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/-γc-/-(RAG-hu) mice. Virology 373:342-51
201. + cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus. J. Virol. 82:12145-53
202. Cheroutre H, Lambolez F, Mucida D. 2011. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 11:445-56
203. Denton PW, Garcia JV. 2009. Novel humanized murine models for HIV research. Curr. HIV/AIDS Rep. 6:13-19
204. Tonomura N, Habiro K, Shimizu A, SykesM, Yang YG. 2008. Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood 111:4293-96
205. Lowry PA, Shultz LD, Greiner DL, Hesselton RM, Kittler EL, et al. 1996. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol. Blood Marrow Transplant. 2:15-23
206. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L. 1996. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 88:3731-40
207. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, et al. 2012. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149:1578-93